It suppresses gastric cancer cell proliferation by downregulating ASCT2-mediated glutamine uptake, modulating c-Myc, GSK3β, and AKT phosphorylation, and inducing ROS-mediated apoptosis via Nrf2 suppression, effectively inhibiting in vivo tumor growth [26]. This evidence concerns the gene SLC1A5 and neoplasm.